BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 31427056)

  • 1. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L; Spiera R
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell arteritis and polymyalgia rheumatica: an update.
    González-Gay MA; Pina T
    Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
    Becker M
    Praxis (Bern 1994); 2020; 109(5):347-354. PubMed ID: 32233763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J; Warrington KJ
    Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyalgia rheumatic (PMR): giant cell arteritis (GCA).
    Kelly MC
    Ir Med J; 2008; 101(7):222-4. PubMed ID: 18807817
    [No Abstract]   [Full Text] [Related]  

  • 7. Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series.
    Diamantopoulos AP; Hetland H; Myklebust G
    Biomed Res Int; 2013; 2013():120638. PubMed ID: 24106691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.
    Gonzalez-Gay MA; Garcia-Porrua C; Miranda-Filloy JA; Martin J
    Drugs Aging; 2006; 23(8):627-49. PubMed ID: 16964987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica.
    El Chami S; Springer JM
    Rheum Dis Clin North Am; 2022 May; 48(2):493-506. PubMed ID: 35400374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-giant cell arteritis of the temporal artery presenting as the polymyalgia rheumatica-temporal arteritis syndrome.
    Lesser RS; Aledort D; Lie JT
    J Rheumatol; 1995 Nov; 22(11):2177-82. PubMed ID: 8596167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyalgia rheumatica and temporal arteritis.
    Allen NB; Studenski SA
    Med Clin North Am; 1986 Mar; 70(2):369-84. PubMed ID: 3512931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myalgias and Myopathies: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Mansalis K
    FP Essent; 2016 Jan; 440():16-22. PubMed ID: 26734832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymyalgia rheumatica: myalgic syndrome or occult vasculitis?].
    Hellmich B; Gross WL
    Internist (Berl); 2005 Nov; 46(11):1233-43. PubMed ID: 16151786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis.
    Man-Ger Sun M; Pope JE
    Best Pract Res Clin Rheumatol; 2022 Dec; 36(4):101822. PubMed ID: 36907732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant cell arteritis-a systemic spectrum including temporal arteritis and polymyalgia rheumatica.
    Atkins SD
    J Fam Pract; 1978 Dec; 7(6):1109-11. PubMed ID: 748486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of polymyalgia rheumatica and giant cell arteritis.
    Salvarani C; Pipitone N; Versari A; Hunder GG
    Nat Rev Rheumatol; 2012 Sep; 8(9):509-21. PubMed ID: 22825731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
    Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
    Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
    Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.